Julia G. Butchko, Chief Development Officer at Immunovant, Inc. (IMVT), sold 12,405 shares at $29.94 ($362K) on 2024-04-17, disclosed to the SEC on 2024-04-19.
Open-market sale of $362k IMVT by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.80 | 7,825 | $225K | 62.2% |
| 2 | $29.94 | 2,290 | $69K | 18.9% |
| 3 | $29.94 | 2,290 | $69K | 18.9% |
| Total | $29.22 avg | 12,405 | $362K | 100% |
| Filing → |
| IMVT | SELL | 2024-07-10 | $43K | — | Filing → |
| IMVT | SELL | 2024-05-24 | $193K | — | Filing → |
| IMVT | SELL | 2024-04-10 | $33K | — | Filing → |